TIMP1 and acute myeloid leukemia: We firstly observed that the addition of TIMP-1 resulted in pAkt-Thr308 phosphorylation of CD63+, but not CD63–, AML cells (Figure 6D), confirming that CD63 binding may be important to pAkt activation by TIMP-1.